Cboe UK CHF
Galderma Group AG (GALDZ.XC)
92.70
+2.70
+(3.00%)
At close: April 25 at 4:19:58 PM GMT+1
Breakdown
TTM
12/31/2024
12/31/2023
Operating Cash Flow
488,000
488,000
165,000
Investing Cash Flow
-326,000
-326,000
-174,000
Financing Cash Flow
-58,000
-58,000
142,000
End Cash Position
457,000
457,000
368,000
Capital Expenditure
-275,000
-275,000
-153,000
Issuance of Capital Stock
2,166,000
2,166,000
1,011,000
Issuance of Debt
3,601,000
3,601,000
856,000
Repayment of Debt
-5,777,000
-5,777,000
-1,725,000
Repurchase of Capital Stock
-15,000
-15,000
--
Free Cash Flow
213,000
213,000
12,000
12/31/2023 - 4/3/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade